{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:01:23Z","timestamp":1790269283351,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant peritoneal mesothelioma (MPM) is a rare malignancy for which cytoreductive surgery (CRS), usually combined with hyperthermic intraperitoneal chemotherapy, is considered in selected patients. However, resectability may be difficult to assess preoperatively, particularly when small-bowel or mesenteric involvement is suspected. The primary aim was to describe CRS outcomes, with a secondary exploratory aim of evaluating the role of diagnostic laparoscopy in patient selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed 45 consecutive patients with MPM who underwent surgical assessment of resectability between 2008 and 2025. Surgical outcomes after CRS and overall survival were evaluated. Patient selection according to the initial surgical assessment strategy and reasons for non-CRS were also assessed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen patients underwent upfront exploratory laparotomy and 27 underwent diagnostic laparoscopy. CRS was ultimately performed in 22 patients: 13 after upfront laparotomy and 9 after diagnostic laparoscopy. Among patients undergoing CRS, complete or near-complete cytoreduction (CC-0\/1) was achieved in 5 of 13 patients (38%) in the upfront laparotomy group and in all 9 patients (100%) selected for CRS after diagnostic laparoscopy. Among the 18 patients who did not proceed to CRS after diagnostic laparoscopy, 17 had extensive small-bowel and\/or mesenteric involvement. The 5-year overall survival after CRS was 52%, and was 58% in patients with CC-0\/1 cytoreduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CRS was associated with encouraging long-term survival in carefully selected patients with MPM. Diagnostic laparoscopy may facilitate assessment of resectability, particularly when small-bowel or mesenteric involvement is uncertain, and may help avoid non-therapeutic laparotomy in selected patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyag166","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:48:28Z","timestamp":1788954508000},"source":"Crossref","is-referenced-by-count":0,"title":["Cytoreductive surgery for malignant peritoneal mesothelioma: importance of patient selection using diagnostic laparoscopy"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2110-8220","authenticated-orcid":false,"given":"Akiyoshi","family":"Mizumoto","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takao","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Imagami","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumitsu","family":"Oe","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsunaga","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Sogawa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-6555","authenticated-orcid":false,"given":"Byonggu","family":"An","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Togawa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery and Peritoneal Dissemination Center, Omi Medical Center , Yabase-Cho 1660, Kusatsu City, Shiga ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092412094946600_ref1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim","year":"2017","journal-title":"Ann Transl Med"},{"key":"2026092412094946600_ref2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/dmr-22-19","article-title":"Malignant peritoneal mesothelioma literature review: past, present, and future","volume":"5","author":"Gregory","year":"2022","journal-title":"Dig Med Res"},{"key":"2026092412094946600_ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194704","article-title":"Malignant peritoneal mesothelioma: an in-depth and up-to-date review of pathogenesis, diagnosis, management and future directions","volume":"15","author":"Karpes","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026092412094946600_ref4","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","article-title":"Peritoneal mesothelioma","volume":"9","author":"Greenbaum","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"2026092412094946600_ref5","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026092412094946600_ref6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"2026092412094946600_ref7","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Cancer"},{"key":"2026092412094946600_ref8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2026092412094946600_ref9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2026092412094946600_ref10","first-page":"187","article-title":"Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal mesothelioma","volume":"23","author":"Laterza","year":"2009","journal-title":"In Vivo"},{"key":"2026092412094946600_ref11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/jso.23924","article-title":"Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal surface malignancies","volume":"111","author":"Tabrizian","year":"2015","journal-title":"J Surg Oncol"},{"key":"2026092412094946600_ref12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s13193-015-0486-9","article-title":"Diagnostic laparoscopy in the pre-operative assessment of patients undergoing cytoreductive surgery and HIPEC for peritoneal surface malignancies","volume":"7","author":"Seshadri","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"2026092412094946600_ref13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"2026092412094946600_ref14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"2026092412094946600_ref15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026092412094946600_ref16","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2026092412094946600_ref17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41379-020-00688-4","article-title":"Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases","volume":"34","author":"Chapel","year":"2021","journal-title":"Mod Pathol"},{"key":"2026092412094946600_ref18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"UNICANCER-GI Group and BIG Renape Group. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026092412094946600_ref19","doi-asserted-by":"publisher","first-page":"e35868","DOI":"10.1002\/cncr.35868","article-title":"Peritoneal Surface Malignancies Consortium Group. Consensus guideline for the management of peritoneal mesothelioma","volume":"131","author":"Brown","year":"2025","journal-title":"Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyag166\/71382256\/hyag166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyag166\/71382256\/hyag166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:09:51Z","timestamp":1790266191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article\/doi\/10.1093\/jjco\/hyag166\/8833835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag166","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"hyag166"}}